Physician profile
Wayne S Orr
NPI 1013132406
$3,252.96
in general payments reported to CMS, 2019-2025
14 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $273 · 2021: $341 · 2022: $517 · 2023: $514 · 2024: $565 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $969.71 | 2023-2025 | |
| Baxter Healthcare | $783.82 | 2019-2024 | Tisseel |
| Boston Scientific Corporation | $349.91 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $224.62 | 2021-2023 | Signia, Gia |
| Carl Zeiss Meditec USA, INC. | $212.84 | 2022 | |
| Somavac Medical Solutions, INC. | $194.40 | 2024 | Somavac 100 Sustained Vacuum System |
| Intuitive Surgical, INC. | $138.03 | 2019-2024 | Da Vinci Surgical System |
| Acera Surgical, INC. | $137.43 | 2023 | Restrata Wound Matrix |
| Glaxosmithkline, LLC. | $94.33 | 2023 | Zejula |
| Covidien Lp | $68.33 | 2019 | |
| Angiodynamics, INC. | $28.28 | 2019 | |
| Mauna Kea Technologies, INC. | $26.63 | 2024 | |
| Merck Sharp & Dohme LLC | $12.64 | 2019 | |
| Eisai INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.